Friday, May 04, 2007

Brazil bypasses patent on AIDS drug

Talks recently between Brazil and pharmaceutical giant, Merck, break down over AIDS drug. Lula de Silval, president of Brazil, issued a "compulsory license" to bypass patent of Merck's drug efavirenz. This license lets Brazil make the drug or buy generics with only paying a small fee to patent holder. The country of Brazil allows for compulsory licenses in a health emergency, and this was done for a case of abusive pricing with AIDS medicine.

To read the whole story, go here.

No comments: